MENU
CGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cognition Therapeutics (CGTX) Ownership - Who owns Cognition Therapeutics?
Profile
Industry
N/A
Address
2500 Westchester Avenue
Phone
+1 412 481-2210
Employees
28
Web
https://www.cogrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.9M
P/E Ratio
N/A
Total Cash
22.01M
Projected Growth
N/A
Total Debt
580K
Revenue
N/A
Risk (Beta)
1.35
Dividend Yield
N/A
Total Cash/Share
0.53
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CGTX
Capitalization
18.9M
P/E Ratio
N/A
Risk (Beta)
1.35
Dividend Yield
N/A
Total Cash
22M
Total Cash/Share
0.53
Total Debt
580K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
14.5M
P/B Ratio
1.31
Cash Flow
N/A
Earnings
-0.96
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
41K
Current Ratio
2.11
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-33.98M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-103.30
Shares Held By Institutions
6.91M
Shares Outstanding - Current
41.5M
Total Liabilities
13.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-75.411
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2500 Westchester Avenue
Phone
+1 412 481-2210
Employees
28
Web
https://www.cogrx.com